Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.49 USD | +4.97% | +3.58% | -14.88% |
04-16 | Foghorn Therapeutics Names Kristian Humer CFO | MT |
04-16 | Foghorn Therapeutics Inc. Appoints Kristian Humer as Chief Financial Officer | CI |
Business Summary
Number of employees: 116
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines
100.0
%
| 19 | 100.0 % | 34 | 100.0 % | +77.63% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 19 | 100.0 % | 34 | 100.0 % | +77.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 30/04/17 | |
Douglas Cole
FOU | Founder | 63 | 30/09/15 |
Fanny Cavalié
COO | Chief Operating Officer | 46 | - |
Steven Bellon
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/05/16 |
Chief Tech/Sci/R&D Officer | 53 | 10/09/23 | |
Andrew Germain
LAW | General Counsel | - | 31/12/19 |
Saurabh Sewak
PRN | Corporate Officer/Principal | - | 31/12/21 |
Carlos Costa
HRO | Human Resources Officer | 51 | - |
Michael LaCascia
LAW | General Counsel | 59 | 11/11/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simba Gill
BRD | Director/Board Member | 60 | 30/06/17 |
Douglas Cole
FOU | Founder | 63 | 30/09/15 |
B. Parshall
BRD | Director/Board Member | 69 | 15/08/22 |
Ian Smith
BRD | Director/Board Member | 58 | 26/04/21 |
Adam Koppel
BRD | Director/Board Member | 54 | 30/06/17 |
Thomas Lynch
BRD | Director/Board Member | 63 | 26/10/22 |
Director/Board Member | 69 | 31/03/17 | |
Scott Biller
BRD | Director/Board Member | 68 | 08/01/20 |
Chief Executive Officer | 49 | 30/04/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,565,904 | 32,012,092 ( 75.21 %) | 0 | 75.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.88% | 234M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- FHTX Stock
- Company Foghorn Therapeutics Inc.